URMC »Research » Research@URMC Blog » June 2014

June 2014

Nature Gives Shout-Out to Wilmot for Immune Therapy Research

One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.

6/4/2014 | 0 comments

Targeting Metabolic Syndrome to Treat Multiple Signs of Aging

A recent study by University of Rochester School of Medicine and Dentistry researchers published in the International Journal of Geriatric Psychiatry begins to unravel the relationship between metabolic syndrome, frailty and cognition. The authors found that having metabolic syndrome significantly increased the chances of becoming physically frailer and slower in cognitive abilities, such as slower in recalling something that happened half an hour ago.

6/4/2014 | 0 comments

It takes two to tango in HIV-associated brain damage

HIV-associated brain damage occurs extensively, even in patients who are taking otherwise effective traditional anti-HIV therapy. This is a result of potent cooperation between two types of special immunological cells within the brain called monocytes and platelets. A recent paper published by University researchers in the Journal of Immunology demonstrates the presence of these platelet-monocyte ‘teams’ in HIV infected individuals and how these teams lead to increased neuronal damage.

 

6/3/2014 | 2 comments
12